Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Operating Leases (2019 - 2025)

Grifols' (GIFLF) quarterly Operating Leases came in at $1.1 billion in Q4 2025, up 2.98% on a YoY basis from $1.1 billion in Q4 2024, and up 2.98% quarter-over-quarter from $1.1 billion in Q4 2024.

Analysis

Grifols (GIFLF) Operating Leases (2019 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Operating Leases for 7 consecutive years, with $1.1 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 2.98% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $1.1 billion (up 2.98% YoY), and the FY2025 full-year result was $1.1 billion, changed 0.05% from the prior year.
  • Operating Leases grew to $1.1 billion in Q4 2025 per GIFLF's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Operating Leases topped out at $1.1 billion in Q4 2025 and bottomed at $933.1 million in Q4 2022.
  • Historically, Operating Leases has averaged $1.0 billion across 5 years, with a median of $1.1 billion in 2023.
  • The sharpest annual moves came in 2022 and 2023: Operating Leases fell 1.15% in 2022, then advanced 15.79% in 2023.
  • Over 5 years, Operating Leases stood at $944.0 million in 2021, then fell by 1.15% to $933.1 million in 2022, then increased by 15.79% to $1.1 billion in 2023, then grew by 1.37% to $1.1 billion in 2024, then advanced by 2.98% to $1.1 billion in 2025.
  • According to Business Quant data, Operating Leases over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.13 Bn
Dec 31, 2024 1.10 Bn
Dec 31, 2023 1.08 Bn
Dec 31, 2022 933.11 Mn
Dec 31, 2021 943.96 Mn
Dec 31, 2020 823.70 Mn
Dec 31, 2019 770.71 Mn